Trial intelligence / Profile preview

Travacom in uncontrolled intraocular pressure

NCT01159756Phase 4Completed

Sponsor
Alcon Inc.
Start
Jul 2010
Primary completion
Nov 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of travoprost + timolol in Open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Jul 2010; status: completed.

02

Drugs

travoprost + timolol
03

Conditions

Open-angle glaucoma (OAG)ocular hypertension

Beyond the preview

Go deeper on NCT01159756.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01159756.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call